Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Satoshi Iwayama is active.

Publication


Featured researches published by Satoshi Iwayama.


Bioorganic & Medicinal Chemistry Letters | 2011

Asymmetric synthesis and biological evaluations of (+)- and (−)-6-dimethoxymethyl-1,4-dihydropyridine-3-carboxylic acid derivatives blocking N-type calcium channels

Takashi Yamamoto; Seiji Ohno; Seiji Niwa; Munetaka Tokumasu; Masako Hagihara; Hajime Koganei; Shinichi Fujita; Tomoko Takeda; Yuki Saitou; Satoshi Iwayama; Akira Takahara; Seinosuke Iwata; Masataka Shoji

An efficient asymmetric synthesis of 1,4-dihydropyridine derivatives is described. The key step is the stereoselective Michael addition using t-butyl ester of L-valine as a chiral auxiliary to achieve good ee (>95% for all the tested experiments) and moderate yield. With this method, (+)-4-(3-chlorophenyl)-6-dimethoxymethyl-2-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid cinnamyl ester was obtained and was characterized as a promising N-type calcium channel blocker with improved selectivity over L-type compared to its (-)- and racemic isomers.


Bioorganic & Medicinal Chemistry Letters | 2012

Discovery and evaluation of selective N-type calcium channel blockers: 6-Unsubstituted-1,4-dihydropyridine-5-carboxylic acid derivatives

Takashi Yamamoto; Seiji Niwa; Munetaka Tokumasu; Tomoyuki Onishi; Seiji Ohno; Masako Hagihara; Hajime Koganei; Shinichi Fujita; Tomoko Takeda; Yuki Saitou; Satoshi Iwayama; Akira Takahara; Seinosuke Iwata; Masataka Shoji

A structure-activity relationship study of 6-unsubstituted-1,4-dihydropyridine and 2,6-unsubstituted-1,4-dihydropyridine derivatives was conducted in an attempt to discover N-type calcium channel blockers that were highly selective over L-type calcium channel blockers. Among the tested compounds, (+)-4-(3,5-dichloro-4-methoxy-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-cinnamyl ester was found to be an effective and selective N-type calcium channel blocker with oral analgesic potential.


Journal of Medicinal Chemistry | 1998

Synthesis and Antiviral Activity of Novel Acyclic Nucleosides: Discovery of a Cyclopropyl Nucleoside with Potent Inhibitory Activity against Herpesviruses

Takaaki Sekiyama; Satoshi Hatsuya; Yasuhiro Tanaka; Mamoru Uchiyama; Nobukazu Ono; Satoshi Iwayama; Miki Oikawa; Katsuya Suzuki; Masahiko Okunishi; Takashi Tsuji


Bioorganic & Medicinal Chemistry Letters | 2007

Synthesis and evaluation of isoxazole derivatives as lysophosphatidic acid (LPA) antagonists

Takashi Yamamoto; Koichi Fujita; Sayaka Asari; Akira Chiba; Yuka Kataba; Koji Ohsumi; Naoko Ohmuta; Yuko Iida; Chiori Ijichi; Satoshi Iwayama; Naoyuki Fukuchi; Masataka Shoji


Hypertension Research | 2003

Neuronal Ca2+ Channel Blocking Action of an Antihypertensive Drug, Cilnidipine, in IMR-32 Human Neuroblastoma Cells

Akira Takahara; Shinichi Fujita; Keiko Moki; Yukitsugu Ono; Hajime Koganei; Satoshi Iwayama; Hiroshi Yamamoto


Antimicrobial Agents and Chemotherapy | 1998

Antiherpesvirus Activities of (1′S,2′R)-9-{[1′,2′-Bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine (A-5021) in Cell Culture

Satoshi Iwayama; Nobukazu Ono; Yuko Ohmura; Katsuya Suzuki; Miho Aoki; Harumi Nakazawa; Miki Oikawa; Tamamo Kato; Masahiko Okunishi; Yukihiro Nishiyama; Koichi Yamanishi


Journal of Medicinal Chemistry | 2000

Synthesis and Antiviral Activity of Novel Anti-VZV 5-Substituted Uracil Nucleosides with a Cyclopropane Sugar Moiety

Tomoyuki Onishi; Chika Mukai; Ryusuke Nakagawa; Takaaki Sekiyama; Miho Aoki; Katsuya Suzuki; Harumi Nakazawa; Nobukazu Ono; Yuko Ohmura; Satoshi Iwayama; Masahiko Okunishi; Takashi Tsuji


Bioorganic & Medicinal Chemistry | 2006

Discovery, structure–activity relationship study, and oral analgesic efficacy of cyproheptadine derivatives possessing N-type calcium channel inhibitory activity

Takashi Yamamoto; Seiji Niwa; Satoshi Iwayama; Hajime Koganei; Shinichi Fujita; Tomoko Takeda; Morikazu Kito; Yukitsugu Ono; Yuki Saitou; Akira Takahara; Seinosuke Iwata; Hiroshi Yamamoto; Masataka Shoji


Antimicrobial Agents and Chemotherapy | 1998

Mode of Action of (1′S,2′R)-9-{[1′,2′-Bis(hydroxymethyl) cycloprop-1′-yl]methyl}guanine (A-5021) against Herpes Simplex Virus Type 1 and Type 2 and Varicella-Zoster Virus

Nobukazu Ono; Satoshi Iwayama; Katsuya Suzuki; Takaaki Sekiyama; Harumi Nakazawa; Takashi Tsuji; Masahiko Okunishi; Tohru Daikoku; Yukihiro Nishiyama


Archive | 2004

Novel azole compound

Takashi Yamamoto; Akira Chiba; Kouichi Fujita; Yuka Kataba; Koji Ohsumi; Sayaka Asari; Naoyuki Fukuchi; Misato Noguchi; Itsuya Tanabe; Chiori Ijichi; Naoko Oohmuta; Yuko Iida; Satoshi Iwayama

Collaboration


Dive into the Satoshi Iwayama's collaboration.

Researchain Logo
Decentralizing Knowledge